Jazz Pharmaceuticals JAZZ Effective Income Tax Rate Reconciliation, Patent Box Incentive Benefit, Percent
Effective Income Tax Rate Reconciliation, Patent Box Incentive Benefit, Percent at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitPercent.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's effective income tax rate reconciliation, patent box incentive benefit, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's effective income tax rate reconciliation, patent box incentive benefit, percent?
- Jazz Pharmaceuticals (JAZZ) reported effective income tax rate reconciliation, patent box incentive benefit, percent of -9.7% in Q4 2025.
- What does effective income tax rate reconciliation, patent box incentive benefit, percent mean?
- The percentage reduction in the effective tax rate due to patent box tax incentives.
- How do you interpret effective income tax rate reconciliation, patent box incentive benefit, percent?
- A higher percentage indicates that patent-related tax incentives are a major contributor to tax optimization.
- How does effective income tax rate reconciliation, patent box incentive benefit, percent compare across companies?
- Standard metric for R&D-intensive firms; reflects the strategic importance of IP-based tax planning.